A detailed history of Ballentine Partners, LLC transactions in Sanofi stock. As of the latest transaction made, Ballentine Partners, LLC holds 15,446 shares of SNY stock, worth $839,335. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,446
Previous 12,644 22.16%
Holding current value
$839,335
Previous $729,000 2.19%
% of portfolio
0.01%
Previous 0.01%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025

BUY
$45.89 - $57.31 $128,583 - $160,582
2,802 Added 22.16%
15,446 $745,000
Q3 2024

Oct 23, 2024

BUY
$48.54 - $58.53 $111,447 - $134,384
2,296 Added 22.19%
12,644 $729,000
Q2 2024

Aug 06, 2024

BUY
$45.39 - $50.36 $107,619 - $119,403
2,371 Added 29.72%
10,348 $502,000
Q1 2024

Apr 11, 2024

BUY
$45.75 - $52.48 $24,659 - $28,286
539 Added 7.25%
7,977 $387,000
Q4 2023

Jan 23, 2024

BUY
$43.13 - $54.79 $17,338 - $22,025
402 Added 5.71%
7,438 $369,000
Q3 2023

Oct 19, 2023

BUY
$50.95 - $55.2 $30,570 - $33,120
600 Added 9.32%
7,036 $377,000
Q2 2023

Jul 26, 2023

BUY
$50.45 - $57.18 $136,013 - $154,157
2,696 Added 72.09%
6,436 $346,000
Q1 2023

Apr 27, 2023

BUY
$45.86 - $54.45 $171,516 - $203,643
3,740 New
3,740 $203,000
Q2 2022

Aug 09, 2022

SELL
$48.99 - $57.46 $161,960 - $189,962
-3,306 Reduced 38.32%
5,322 $267,000
Q1 2022

May 05, 2022

BUY
$48.48 - $53.65 $418,285 - $462,892
8,628 New
8,628 $443,000
Q4 2021

Feb 14, 2022

SELL
$47.07 - $52.35 $236,291 - $262,797
-5,020 Closed
0 $0
Q3 2021

Oct 27, 2021

SELL
$47.89 - $53.12 $37,833 - $41,964
-790 Reduced 13.6%
5,020 $242,000
Q2 2021

Aug 12, 2021

SELL
$49.36 - $54.25 $35,391 - $38,897
-717 Reduced 10.99%
5,810 $306,000
Q1 2021

May 11, 2021

BUY
$45.46 - $50.51 $19,547 - $21,719
430 Added 7.05%
6,527 $323,000
Q4 2020

Jan 25, 2021

SELL
$45.3 - $51.62 $3,805 - $4,336
-84 Reduced 1.36%
6,097 $296,000
Q3 2020

Oct 22, 2020

BUY
$49.47 - $53.77 $10,289 - $11,184
208 Added 3.48%
6,181 $310,000
Q2 2020

Jul 31, 2020

SELL
$42.91 - $52.5 $21,497 - $26,302
-501 Reduced 7.74%
5,973 $305,000
Q1 2020

Apr 23, 2020

BUY
$38.02 - $51.66 $14,789 - $20,095
389 Added 6.39%
6,474 $283,000
Q4 2019

Jan 22, 2020

BUY
$44.25 - $50.86 $32,922 - $37,839
744 Added 13.93%
6,085 $305,000
Q3 2019

Oct 21, 2019

BUY
$40.34 - $46.64 $19,201 - $22,200
476 Added 9.78%
5,341 $247,000
Q2 2019

Jul 25, 2019

BUY
$40.43 - $44.3 $525 - $575
13 Added 0.27%
4,865 $210,000
Q1 2019

May 09, 2019

BUY
$40.83 - $45.43 $198,107 - $220,426
4,852 New
4,852 $214,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $136B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.